Ranolazine Krka 750 mg prolonged-release tablets

Licence status
Authorised: 31/03/2023
Active substances
Ranolazine
Dosage Form
Prolonged-release tablet
Licence number
PA1347/109/003
Licence holder
KRKA, d.d., Novo mesto

Product documents

Licence information

ATC code
C01EB18 ranolazine
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
31/03/2023

Interchangeable information